Neurocrine Biosciences added to STI Equity Trades Portfolio
As described in today’s edition of Smart Tech 50 Weekly Movers, we are adding Neurocrine Biosciences (NSDQ: NBIX) to the STI Equity Trades Portfolio with a buy limit of $46, and a stop loss of $36.
Stock Talk
Add New Comments
You must be logged in to post to Stock Talk OR create an account